Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JMS CoTSE:7702 +0.44%60 EV-to-EBIT is 116.98 as of Sep. 13, 2026, which is 383% above its 10-year median of 24.24. GuruFocus rates TSE:7702 with a GF Score™ of 60/100 and a GF Value™ of 円509.07 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 474 Medical Devices & Instruments companies, JMS Co ranks worse than 93.04% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, JMS Co's Enterprise Value is 円28,542 Mil.
JMS Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was 円244 Mil. Therefore, JMS Co's EV-to-EBIT for today is 116.98.
The historical rank and industry rank for JMS Co's EV-to-EBIT or its related term are showing as below:
TSE:7702'
s EV-to-EBIT Range Over the Past 10 Years
Min: -116.65 Med: 24.24 Max: 817.93
Current: 116.98
During the past 13 years, the highest EV-to-EBIT of JMS Co was 817.93. The lowest was -116.65. And the median was 24.24.
TSE:7702's EV-to-EBIT is ranked worse than 93.04% of 474
companies
in the Medical Devices & Instruments industry
Industry Median: 18.005
vs TSE:7702: 116.98
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
JMS Co's Enterprise Value for the quarter that ended in Mar. 2026 was 円30,771 Mil.
JMS Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円244 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JMS Co EV-to-EBIT Related Terms
JMS Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for JMS Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, JMS Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMS Co EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JMS Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where JMS Co's EV-to-EBIT falls into.
JMS Co's current Enterprise Value is 円28,542 Mil.
JMS Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円244 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JMS Co (TSE:7702) has a EV-to-EBIT of 116.98 as of Sep. 13, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on JMS Co and its competitors. This is 383% above median its historical median of 24.24. According to the industry distribution chart, JMS Co ranks #441 out of 474 companies in the Medical Devices & Instruments industry, placing it in the top 93%.
Is JMS Co's EV-to-EBIT too high?
JMS Co's current EV-to-EBIT of 116.98 is 383% above median its 10-year median of 24.24. The Medical Devices & Instruments industry median EV-to-EBIT is 18.01. JMS Co's value of 116.98 is 549.7% above this industry median. Based on the distribution chart, JMS Co ranks #441 out of 474 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, JMS Co has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JMS Co's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JMS Co ranks #441 out of 474 companies for EV-to-EBIT. This places JMS Co in the lower half of its industry. The industry median EV-to-EBIT is 18.01. JMS Co's value of 116.98 is 549.7% above this benchmark. While the company's 10-year median is 24.24 vs. the industry median of 18.01, JMS Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.01, based on 474 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JMS Co's current EV-to-EBIT of 116.98 is 549.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on JMS Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JMS Co's current EV-to-EBIT is 116.98, which is 383% above median its own 10-year median of 24.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMS Co stock overvalued right now?
Based on GuruFocus' analysis, JMS Co (TSE:7702) is currently considered Modestly Undervalued. The stock's GF Value™ is 円509.07, compared to a current price of 円453.00 — trading 11% below its estimated fair value. The current EV-to-EBIT is 116.98, which is 383% above median its 10-year median of 24.24 and 549.7% above the Medical Devices & Instruments industry median of 18.01. JMS Co's overall GF Score™ is 60/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For JMS Co (TSE:7702), the current EV-to-EBIT is 116.98 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JMS Co (TSE:7702) Overvalued in 2026?
Based on GuruFocus' analysis, JMS Co stock appears to be undervalued.
The current stock price of 円453.00 is trading 11% below its estimated GF Value™ of 円509.07.
GuruFocus considers JMS Co to be Modestly Undervalued.
Key valuation signals for TSE:7702:
EV-to-EBIT: 116.98 (383% above median its 10-year median of 24.24)
GF Value™: 円509.07 vs. price of 円453.00 (11% below fair value)
Industry Position: 549.7% above the Medical Devices & Instruments median (#441 of 474)
No single metric tells the full story. See the TSE:7702 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JMS Co Ltd is a Japan-based medical equipment manufacturer. The company is engaged in the manufacture, sale, export, and import of medical equipment and pharmaceuticals. Products offered by the company include an infusion pump, syringe pump, surgical gown, peritoneal dialysate, dialyzer, mask cap, sheet for treatment, pacemaker, heat exchanger, blood bag, among others. JMS has network operations in various countries including Europe, North America, Asia, the Middle East, Latin America and Africa.
60GF Score
Get the complete analysis for TSE:7702
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7702 has been successfully added to your 
